Thaçi, D. et al. 2026. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials. Acta Dermato-Venereologica. 106, (May 2026), adv–2025. DOI:https://doi.org/10.2340/actadv.v106.adv-2025-0160.